Long-term treatment with clozapine is associated with a small, but significant, risk of hematological malignancies in individuals with schizophrenia, new research shows. Investigators found long-term ...

One in 3 people with schizophrenia don’t respond to antipsychotics — but previous blood test requirements made clozapine difficult to access. The FDA removed a requirement for patients to submit blood ...

In the U.S., schizophrenia remains one of the most severe and debilitating mental health conditions, with effective treatment often out of reach for those who need them most. Clozapine, a medication ...

S&PAA and AAPP launch A New Era in Clozapine Management—a free, accredited training to guide clinicians in post-REMS clozapine care. The curriculum includes seven expert-led modules that address ...